RI
AGN

Ridgewood Investments’s Allergan plc AGN Stock Holding History

Ridgewood Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,959
Closed -$347K – 185
2020
Q1 		$347K Sell
1,959
-837
-30% -$158K 0.35% 90
2019
Q4 		$535K Sell
2,796
-12
-0.4% -$2.17K 0.38% 82
2019
Q3 		$473K Sell
2,808
-1,030
-27% -$168K 0.37% 87
2019
Q2 		$643K Buy
3,838
+2,096
+120% +$290K 0.5% 51
2019
Q1 		$255K Buy
+1,742
New +$253K 0.21% 142

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Ridgewood Investments's AGN Position: Q2 2020 in Review

Ridgewood Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,959 shares — an estimated $347K sold.

Ridgewood Investments first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $643K in Q2 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ridgewood Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ridgewood Investments sold 1,959 Allergan plc shares in Q2 2020, an estimated $347K.
  • Ridgewood Investments first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • Ridgewood Investments's Allergan plc position peaked at $643K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ridgewood Investments's 13F filing for Q2 2020, filed 10 Aug 2020.